Short Course Oncology Therapy: a study of adjuvant chemotherapy in colorectal cancer by the CACTUS and OCTO collaborative groups.

 

Trial Summary:

This study is investigating the efficacy of 3 months of adjuvant chemotherapy versus 6 months in terms of 3-year disease-free survival, overall survival, toxicity, cost-effectiveness and quality of life.

Supported By:

CACTUS; Cancer Australia; NHMRC CTC; AGITG

Eligibility:

Patients with fully resected stage III colorectal cancer

Registration ID:

ACTRN12609000662268

Participation:

International

Australian Lead Group:

AGITG

Status:

close out

Activation Date:

18/03/2010

Chairs:

Tim Iveson (international), Andrew Haydon (Australia)

Contact:

scot@ctc.usyd.edu.au